RNAi Screening in Primary Human Hepatocytes of Genes Implicated in Genome-Wide Association Studies for Roles in Type 2 Diabetes Identifies Roles for CAMK1D and CDKAL1, among Others, in Hepatic Glucose Regulation

• Steven Haney ,

  * E-mail: haney_steven_a@lilly.com

  Current address: Department of Quantitative Biology, Eli Lilly Pharmaceuticals, Indianapolis, Indiana, United States of America

  Affiliation Target Generation Unit, Pfizer Research Technology Center, Cambridge, Massachusetts, United States of America

  ⨯
• Juan Zhao,

  Affiliation Target Generation Unit, Pfizer Research Technology Center, Cambridge, Massachusetts, United States of America

  ⨯
• Shiwani Tiwari,

  Affiliation Target Generation Unit, Pfizer Research Technology Center, Cambridge, Massachusetts, United States of America

  ⨯
• Kurt Eng,

  Current address: Drug Metabolism and Pharmacokinetics, Millennium Pharmaceuticals, Cambridge, Massachusetts, United States of America

  Affiliation Oligonucleotide Therapeutics Unit, Pfizer Research Technology Center, Cambridge, Massachusetts, United States of America

  ⨯
• Lin T. Guey,

  Current address: Department of Biology, Shire Therapeutics HGT, Lexington, Massachusetts, United States of America

  Affiliation Target Generation Unit, Pfizer Research Technology Center, Cambridge, Massachusetts, United States of America

  ⨯
• Eric Tien

  Current address: Discovery Toxicology, Amgen Inc, Thousand Oaks, California, United States of America

  Affiliation Target Generation Unit, Pfizer Research Technology Center, Cambridge, Massachusetts, United States of America

  ⨯